Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,368 public trials 407 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

NCT02599402

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution Garran, Australian Capital Territory, Australia
  • Local Institution Camperdown, New South Wales, Australia
  • Local Institution Coffs Harbour, New South Wales, Australia
  • Local Institution Gateshead, New South Wales, Australia
View all 111 locations
View Trial Details
Completed

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

NCT00414765

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations
  • USC/Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

NCT02296112

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

NCT00118274

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details
Completed

Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma

NCT00896480

Conditions
Atypical Squamous Cells of the Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Wilrijk, Belgium
  • GSK Investigational Site Caen, France
View Trial Details

Related conditions